NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered NAD+ from Heman Peptide HM? Mail in a sample (US only) and let us test it.

Test my supply
+23 more ↓
20%
Finnrick rating
#14 of 21 NAD+ vendors
0 of 3 classifiable tests passed
natural 0% · customers 4.7★ (5)
methodology · Purity focus
Finnrick analysis · NAD+

Repeated purity misses drive the low NAD+ reliability signal under the purity-focus method, with 98.1–99.3% purity and one severe -53% fill result. Latest evidence improved to -15% fill and negative endotoxins, but still misses 99.5%.

methodology →
vendor intelligence report
Vendor Intelligence Report: Heman Peptide HM

Chinese corporate records anchor Heman to a sanitary-products profile, while WHOIS and Wayback show a young but renewed storefront. The report maps Discord/WhatsApp sales, crypto and wire payment rails, referral traffic, and an unresolved high-value agent dispute.

25 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
89%
22
2
Retatrutide
$0.79
84%
65
3
KLOW
$0.29
79%
3
4
Tirzepatide
$0.37
75%
28
5
SS-31
$1.05
69%
4
6
Semax
$0.80
67%
3
7
Ipamorelin
$0.80
66%
5
8
Glutathione
$0.01
62%
3
9
BPC-157
$0.65
62%
11
10
Tesamorelin
$2.00
58%
8
11
TB-500
$1.70
44%
3
12
CJC-1295
$1.85
34%
5
13
MOTS-c
$0.65
32%
5
14
NAD+selected
$0.02
20%
3
15
KPV
$0.70
17%
3
16
5-Amino-1MQ
$1.60
-
0
17
ARA-290
$0.80
-
0
18
Cagrilintide
$2.20
-
0
19
CJC-IPA
$1.15
-
0
20
DSIP
$0.76
-
0
21
Epithalon
$0.38
-
0
22
GLOW
$0.29
-
0
23
IGF-1 LR3
$22.00
-
0
24
Kisspeptin
$1.30
-
0
26
Pinealon
$0.65
-
0
27
PT-141
$0.65
-
0
28
Selank
$0.80
-
0
32
Wolverine
$1.10
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%24 Jun 2026: 32%10 Sep 2026: 24%5 Oct 2026: 20%29 Oct 2026: current 20%32%24%20%Jun 26Oct 26
Showing NAD+ tests only
Heman Peptide HM NAD+ test history
COA-backed lab tests

About Heman Peptide HM test results from Finnrick

Heman Peptide HM is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 171 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Heman Peptide HM peptides in this dataset are BPC-157 (11 tests), CJC-1295 (5 tests) and GHK-Cu (22 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 171 recent tests.

Corrections
No corrections.
Peptide testing

Ordered NAD+ from Heman Peptide HM? Mail in a sample (US only) and let us test it.

Test my supply